Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo.

AIDS

aLaboratoire de Biologie Moléculaire et d'Immunologie (BIOLIM/FSS/UL) bDépartement des sciences fondamentales et biologiques, Faculté des Sciences de la Santé, Université de Lome[Combining Acute Accent], Lomé, Togo cUMI 233, Institut de Recherche pour le Développement (IRD)/INSERM U1175/Université de Montpellier, Montpellier, France dProgramme National de Lutte contre le Sida (PNLS), Lomé, Togo.

Published: November 2015

Information on efficacy of long-term antiretroviral treatment (ART) exposure in resource-limited countries is still scarce. In 767 patients attending routine HIV centers in Togo and receiving first-line ART for more than four years, 42% had viral load greater than 1000 copies/ml and either were on a completely ineffective ART regime or were with only a single drug active. The actual conditions to ensure lifelong ART in resource-limited countries can have dramatic long-term outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000906DOI Listing

Publication Analysis

Top Keywords

long-term antiretroviral
8
antiretroviral treatment
8
routine hiv
8
resource-limited countries
8
alarming rates
4
rates virological
4
virological failure
4
failure drug
4
drug resistance
4
resistance patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!